New approaches to psychiatric diagnostic classification

Neuron

Volumn 84, Issue 3, 2014, Pages 564-571

  Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ATTENTION DEFICIT DISORDER; AUTISM; COMORBIDITY; COPY NUMBER VARIATION; DSM-5; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INCIDENCE; INTELLECTUAL IMPAIRMENT; INTERNATIONAL CLASSIFICATION OF DISEASES; MUTATIONAL ANALYSIS; NEUROSCIENCE; NONHUMAN; PLEIOTROPY; PREVALENCE; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CLASSIFICATION; ECONOMICS; GENETICS; MEDICAL GENETICS; MEDICAL RESEARCH; MENTAL DISORDERS; PROCEDURES; REPRODUCIBILITY;

BIOMEDICAL RESEARCH; GENETICS, MEDICAL; HUMANS; MENTAL DISORDERS; NEUROSCIENCES; REPRODUCIBILITY OF RESULTS;

EID: 84912139868     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.10.028     Document Type: Review

References (39)

1. Abbott A. Novartis to shut brain research facility. Nature 2011, 480:161-162.
2. Allardyce J., Gaebel W., Zielasek J., van Os J. Deconstructing Psychosis conference February 2006: the validity of schizophrenia and alternative approaches to the classification of psychosis. Schizophr. Bull. 2007, 33:863-867.
3. Diagnostic and Statistical Manual ofMental Disorders 2013, American Psychiatric Association, American Psychiatric Publishing, Arlington, VA. Fifth Edition.
4. Berg J.M., Geschwind D.H. Autism genetics: searching for specificity and convergence. Genome Biol. 2012, 13:247.
5. Cooper J.E., Kendell R.E., Gurland B.J., Sharpe L., Copeland J.R.M., Simon R. Psychiatric Diagnosis in New York and London. Maudsley Monograph 20 1972, Oxford University Press, Oxford.
6. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 2005, 186:364-366.
7. Craddock N., Owen M.J. The Kraepelinian dichotomy - going, going. but still not gone. Br. J. Psychiatry 2010, 196:92-95.
8. Craddock N., Jones L., Jones I.R., Kirov G., Green E.K., Grozeva D., Moskvina V., Nikolov I., Hamshere M.L., Vukcevic D., et al. Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol. Psychiatry 2010, 15:146-153. Wellcome Trust Case Control Consortium (WTCCC).
9. Cuthbert B.N. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014, 13:28-35.
10. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013, 11:126.
11. Doherty J.L., Owen M.J. The Research Domain Criteria: moving the goalposts to change the game. Br. J. Psychiatry 2014, 204:171-173.
12. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
13. Gaugler T., Klei L., Sanders S.J., Bodea C.A., Goldberg A.P., Lee A.B., Mahajan M., Manaa D., Pawitan Y., Reichert J., et al. Most genetic risk for autism resides with common variation. Nat. Genet. 2014, 46:881-885.
14. Georgieva L., Rees E., Moran J.L., Chambert K.D., Milanova V., Craddock N., Purcell S., Sklar P., McCarroll S., Holmans P., et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum. Mol. Genet. 2014, Published online July 23, 2014. 10.1093/hmg/ddu379.
15. Girirajan S., Brkanac Z., Coe B.P., Baker C., Vives L., Vu T.H., Shafer N., Bernier R., Ferrero G.B., Silengo M., et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011, 7:e1002334. 10.1371/journal.pgen.1002334.
16. Grant S.G. Synaptopathies: diseases of the synaptome. Curr. Opin. Neurobiol. 2012, 22:522-529.
17. Grozeva D., Kirov G., Ivanov D., Jones I.R., Jones L., Green E.K., St Clair D.M., Young A.H., Ferrier N., Farmer A.E., et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 2010, 67:318-327. Wellcome Trust Case Control Consortium.
18. Hall J., Trent S., Thomas K.L., O'Donovan M.C., Owen M.J. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol. Psychiatry 2014, Published online July 18, 2014. 10.1016/j.biopsych.2014.07.011.
19. Heckers S. Is schizoaffective disorder a useful diagnosis?. Curr. PsychiatryRep. 2009, 11:332-337.
20. Hyman S.E. The diagnosis of mental disorders: the problem of reification. Annu. Rev. Clin. Psychol. 2010, 6:155-179.
21. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167:748-751.
22. 10th Revision 1992, International Statistical Classification of Diseases and Related Health Problems, WHO, Geneva.
23. Kendell R., Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psychiatry 2003, 160:4-12.
24. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 2012, 17:142-153.
25. Lee D.O., Ousley O.Y. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J.Child Adolesc. Psychopharmacol. 2006, 16:737-746.
26. Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., Perlis R.H., Mowry B.J., Thapar A., Goddard M.E., Witte J.S., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45:984-994. Cross-Disorder Group of the Psychiatric Genomics Consortium, International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)International Inflammatory Bowel Disease Genetics Consortium (IIBDGC).
27. Linden D.E.J. The challenges and promise of neuroimaging in psychiatry. Neuron 2012, 73:8-22.
28. Maj M. Keeping an open attitude towards the RDoC project. World Psychiatry 2014, 13:1-3.
29. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
30. McCarroll S.A., Hyman S.E. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 2013, 80:578-587.
31. Narrow W.H., Kuhl E.A. Clinical significance of disorder thresholds in DSM5: the role of disability and distress. The Conceptual Evolution of DSM5 2011, 147-162. American Psychiatric Publishing, Arlington, VA. D.A. Regier, W.E. Narrow, E.A. Kuhl, D.J. Kupfer (Eds.).
32. Owen M.J., O'Donovan M.C., Thapar A., Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 2011, 198:173-175.
33. Pasamanick B., Rogers M.E., Lilienfeld A.M. Pregnancy experience and the development of behavior disorders in children. Am. J. Psychiatry 1956, 112:613-618.
34. Ruderfer D.M., Fanous A.H., Ripke S., McQuillin A., Amdur R.L., Gejman P.V., O'Donovan M.C., Andreassen O.A., Djurovic S., Hultman C.M., et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol. Psychiatry 2014, 19:1017-1024. Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics ConsortiumBipolar Disorder Working Group of the Psychiatric Genomics Consortium, Cross-Disorder Working Group of the Psychiatric Genomics ConsortiumCross-Disorder Working Group of the Psychiatric Genomics Consortium.
35. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427. Schizophrenia Working Group of the Psychiatric Genomics Consortium.
36. Simonoff E., Pickles A., Charman T., Chandler S., Loucas T., Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J.Am. Acad. Child Adolesc. Psychiatry 2008, 47:921-929.
37. Sullivan P.F., Daly M.J., O'Donovan M. Genetic architectures ofpsychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 2012, 13:537-551.
38. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
39. van Os J., Linscott R.J., Myin-Germeys I., Delespaul P., Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 2009, 39:179-195.